Clinical Trial Update: Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study evaluating tacrolimus and mycophenolate mofetil in kidney transplant recipients with hyperkalemia treated with patiromer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia
• Kidney Transplant

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Patiromer (patiromer)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: The Rogosin Institute | Conditions: Hyperkalemia, Kidney Transplant | Phase 4 | Status: COMPLETED